Tower Research Capital LLC (Trc) Addex Therapeutics Ltd. Transaction History

Tower Research Capital LLC (Trc)

  • $3.68 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$0.78 - $16.4 $96 - $2,033
124 New
124 $0
Q1 2021

May 17, 2021
SELL
$9.82 - $14.11 $373 - $536
-38 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$9.79 - $24.19 $372 - $919
38 New
38 $1,000

About Addex Therapeutics Ltd.

ADXN Quotes by TradingView
  • Ticker ADXN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,204,630
  • Market Cap $61.8M
  • Description
  • Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs includ...
More about ADXN
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email